Search results
Results from the WOW.Com Content Network
Levosalbutamol is the INN while levalbuterol is the USAN. Levalbuterol was approved in the United States as a solution to be used with a nebulizer device in March 1999 [7] and in March 2015 became available in a formulation with a metered-dose inhaler under the trade name Xopenex HFA (levalbuterol tartrate inhalation aerosol). [8]
[1] [5] Approximately 85 percent of infants born with a weight less than 2.2 pounds (1 kg) experience infantile apnea within the first month after birth. [4] This risk decreases to 25 percent for infants weighing less than 5.5 pounds (2.5 kg). [4] Studies have found that almost 2% of the pediatric population experience obstructive sleep apnea. [1]
When combined with inhaled steroids, β adrenoceptor agonists can improve symptoms. [1] [2] In children this benefit is uncertain and they may be potentially harmful. [2]They should not be used without an accompanying steroid due to an increased risk of severe symptoms, including exacerbation in both children and adults. [3]
A new study reveals a shocking potential cause for insomnia.
For premium support please call: 800-290-4726 more ways to reach us
Insomnia can be classified as transient, acute, or chronic. Transient insomnia lasts for less than a week. It can be caused by another disorder, by changes in the sleep environment, by the timing of sleep, severe depression, or by stress.
Children of both sexes and all ethnic backgrounds are affected equally. [18] In children younger than three and a half years old, the peak frequency of night terrors is at least one episode per week (up to 3–4 in rare cases). Among older children, the peak frequency of night terrors is one or two episodes per month.
Salbutamol, also known as albuterol and sold under the brand name Ventolin among others, [1] is a medication that opens up the medium and large airways in the lungs. [8] It is a short-acting β 2 adrenergic receptor agonist that causes relaxation of airway smooth muscle. [8]